Drug and Medication Analysis & Statistics, January 2015 (p5)

24/7 Customer Support

Talk to Louis

+1 718 618 4302

Publishers

All regions

121-150 of about 4 400 reports

Purchase Reports From Reputable Market Research Publishers

Colorectal Cancer Drug Pipeline Update 2015

Colorectal Cancer Drug Pipeline Update 2015

  • $ 2 249
  • Industry report
  • January 2015
  • by Bioseeker

Until a decade ago, 5FU/leucovorin formed the mainstay of colorectal cancer treatment but Camptosar and Eloxatin quickly established themselves as components of gold-standard therapy. The advent of Avastin ...

  • Industries : Drug and Medication
Head and Neck Cancer Drug Pipeline Update 2015

Head and Neck Cancer Drug Pipeline Update 2015

  • $ 2 249
  • Industry report
  • January 2015
  • by Bioseeker

There are today 149 companies plus partners developing 168 drugs targeting head and neck cancer in development. In addition, there are 2 suspended drugs and the accumulated number of ceased drugs ove ...

  • Industries : Drug and Medication
Lung Cancer Drug Pipeline Update 2015

Lung Cancer Drug Pipeline Update 2015

  • $ 2 249
  • Industry report
  • January 2015
  • by Bioseeker

Non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC) comprises over 95% of all lung cancers. High unmet needs still persist for this tumor type and despite two decades of extensive R&D ...

  • Industries : Drug and Medication
Ovarian Cancer Drug Pipeline Update 2015

Ovarian Cancer Drug Pipeline Update 2015

  • $ 2 249
  • Industry report
  • January 2015
  • by Bioseeker

With nearly 60,000 cases of ovarian cancer being diagnosed in the seven major markets each year, this cancer type is by no means small and therefore it remains an important secondary indication for existing ...

  • Industries : Drug and Medication
Pancreatic Cancer Drug Pipeline Update 2015

Pancreatic Cancer Drug Pipeline Update 2015

  • $ 2 249
  • Industry report
  • January 2015
  • by Bioseeker

There are today 291 companies plus partners developing 347 drugs targeting pancreatic cancer in development. In addition, there is 1 suspended drug and the accumulated number of ceased drugs over the last ...

  • Industries : Drug and Medication
Prostate Cancer Drug Pipeline Update 2015

Prostate Cancer Drug Pipeline Update 2015

  • $ 2 249
  • Industry report
  • January 2015
  • by Bioseeker

Cancer of the prostate is the second most frequently diagnosed cancer in men in the US. The prostate cancer market is reaching maturity, and major players` sales have been eroded by the launch of various ...

  • Industries : Drug and Medication
Renal Cancer Drug Pipeline Update 2015

Renal Cancer Drug Pipeline Update 2015

  • $ 2 249
  • Industry report
  • January 2015
  • by Bioseeker

The high existing unmet need in the treatment of renal cancer is reflected by the poor prognosis of patients with advanced stage disease, five- year survival rates with existing cytokine therapy being ...

  • Industries : Drug and Medication
Calcium Signaling Pathway in Cancer Drug Pipeline Update 2015

Calcium Signaling Pathway in Cancer Drug Pipeline Update 2015

  • $ 2 249
  • Industry report
  • January 2015
  • by Bioseeker

There are today 183 companies plus partners developing 213 calcium signaling pathway targeting drugs in 865 developmental projects in cancer. In addition, there is 1 suspended drug and the accumulated ...

  • Industries : Drug and Medication
Cell Cycle Targeting in Cancer Drug Pipeline Update 2015

Cell Cycle Targeting in Cancer Drug Pipeline Update 2015

  • $ 2 249
  • Industry report
  • January 2015
  • by Bioseeker

There are today 147 companies plus partners developing 144 targeting the cell cycle drugs in 586 developmental projects in cancer. In addition, there are 2 suspended drugs and the accumulated number of ...

  • Industries : Drug and Medication
Targeting Focal Adhesion for the Treatment of Cancer Drug Pipeline Update 2015

Targeting Focal Adhesion for the Treatment of Cancer Drug Pipeline Update 2015

  • $ 2 249
  • Industry report
  • January 2015
  • by Bioseeker

Cell-matrix adhesions play essential roles in important biological processes including cell motility, cell proliferation, cell differentiation, regulation of gene expression and cell survival. At the ...

  • Industries : Drug and Medication
Targeting Natural Killer Cell Mediated Cytotoxicity in Cancer Drug Pipeline Update 2015

Targeting Natural Killer Cell Mediated Cytotoxicity in Cancer Drug Pipeline Update 2015

  • $ 2 249
  • Industry report
  • January 2015
  • by Bioseeker

Natural killer (NK) cells are lymphocytes of the innate immune system that are involved in early defenses against both allogeneic (nonself) cells and autologous cells undergoing various forms of stress, ...

  • Industries : Drug and Medication
Modulators of the Actin Cytoskeleton for the Treatment of Cancer Drug Pipeline Update 2015

Modulators of the Actin Cytoskeleton for the Treatment of Cancer Drug Pipeline Update 2015

  • $ 2 249
  • Industry report
  • January 2015
  • by Bioseeker

There are today 196 companies plus partners developing 282 targeting actin cytoskeleton modulators drugs in 1242 developmental projects in cancer. In addition, there is 1 suspended drug and the accumulated ...

  • Industries : Drug and Medication
Toll-Like Receptor Signaling Pathway in Cancer Drug Pipeline Update 2015

Toll-Like Receptor Signaling Pathway in Cancer Drug Pipeline Update 2015

  • $ 2 249
  • Industry report
  • January 2015
  • by Bioseeker

Specific families of pattern recognition receptors are responsible for detecting microbial pathogens and generating innate immune responses. Toll-like receptors (TLRs) are membrane-bound receptors identified ...

  • Industries : Drug and Medication
VEGF Signaling Pathway in Cancer Drug Pipeline Update 2015

VEGF Signaling Pathway in Cancer Drug Pipeline Update 2015

  • $ 2 249
  • Industry report
  • January 2015
  • by Bioseeker

There is now much evidence that VEGFR-2 is the major mediator of VEGF-driven responses in endothelial cells and it is considered to be a crucial signal transducer in both physiologic and pathologic angiogenesis. ...

  • Industries : Drug and Medication
Targeting Metabolic Pathways in Cancer Drug Pipeline Update 2015

Targeting Metabolic Pathways in Cancer Drug Pipeline Update 2015

  • $ 2 249
  • Industry report
  • January 2015
  • by Bioseeker

There are today 173 companies plus partners developing 171 metabolic pathways targeting drugs in 478 developmental projects in cancer. In addition, there are 2 suspended drugs and the accumulated numbe ...

  • Industries : Drug and Medication
ErbB Signaling Pathway in Cancer Drug Pipeline Update 2015

ErbB Signaling Pathway in Cancer Drug Pipeline Update 2015

  • $ 2 249
  • Industry report
  • January 2015
  • by Bioseeker

The ErbB family of receptor tyrosine kinases (RTKs) couples binding of extracellular growth factor ligands to intracellular signaling pathways regulating diverse biologic responses, including proliferation, ...

  • Industries : Drug and Medication
Chemokine Signaling Pathway in Cancer Drug Pipeline Update 2015

Chemokine Signaling Pathway in Cancer Drug Pipeline Update 2015

  • $ 2 249
  • Industry report
  • January 2015
  • by Bioseeker

Inflammatory immune response requires the recruitment of leukocytes to the site of inflammation upon foreign insult. Chemokines are small chemoattractant peptides that provide directional cues for the ...

  • Industries : Drug and Medication
Transcriptional Misregulation in Cancer Drug Pipeline Update 2015

Transcriptional Misregulation in Cancer Drug Pipeline Update 2015

  • $ 2 249
  • Industry report
  • January 2015
  • by Bioseeker

There are today 238 companies plus partners developing 279 transcriptional misregulation targeting drugs in 1203 developmental projects in cancer. In addition, there are 4 suspended drugs and the accumulated ...

  • Industries : Drug and Medication
HIF-1 Signaling Pathway in Cancer Drug Pipeline Update 2015

HIF-1 Signaling Pathway in Cancer Drug Pipeline Update 2015

  • $ 2 249
  • Industry report
  • January 2015
  • by Bioseeker

Cancer cells are characterized by rapid proliferation and require adaptive metabolic responses to allow continued biosynthesis and cell growth in the setting of decreased oxygen (O(2)) and nutrient availability. ...

  • Industries : Drug and Medication
Orphan Drugs in Oncology Drug Pipeline Update 2015

Orphan Drugs in Oncology Drug Pipeline Update 2015

  • $ 2 249
  • Industry report
  • January 2015
  • by Bioseeker

This is a worldwide report on cancer drugs which have now or in the past received orphan drug status. This product will give you unique access not only to those cancer indications in which drugs are being ...

  • Industries : Drug and Medication
Conjugated Drugs in Oncology Drug Pipeline Update 2015

Conjugated Drugs in Oncology Drug Pipeline Update 2015

  • $ 2 249
  • Industry report
  • January 2015
  • by Bioseeker

Among conjugated drugs in oncology, antibody-drug conjugates (ADCs) are by far getting the most attention as a new drug class. Owing to improved technology and appropriate targeting, the clinical application ...

  • Industries : Drug and Medication
Mitochondrial Drugs in Oncology Drug Pipeline Update 2015

Mitochondrial Drugs in Oncology Drug Pipeline Update 2015

  • $ 2 249
  • Industry report
  • January 2015
  • by Bioseeker

Focusing on mitochondria has recently become an intriguing target for cancer therapy. It is well known that mitochondrial activity in tumor cells is suppressed and exploiting the differences in mitochondrial ...

  • Industries : Drug and Medication
MicroRNAs in Cancer Drug Pipeline Update 2015

MicroRNAs in Cancer Drug Pipeline Update 2015

  • $ 2 249
  • Industry report
  • January 2015
  • by Bioseeker

The hot entry of microRNA (miRNA) targeting drugs in oncology may come to revolutionize how we in the near future can launch a highly tumor-specific, multi-targeted attack with minimal toxicities eithe ...

  • Industries : Drug and Medication
Austria: Antibiotics - Market Report. Analysis and Forecast to 2020

Austria: Antibiotics - Market Report. Analysis and Forecast to 2020

  • $ 2 161
  • Industry report
  • January 2015
  • by IndexBox Marketing

The report provides an in-depth analysis of the Market for Antibiotics in Austria. It presents the latest data of the market size and volume, domestic production, exports and imports, price dynamics and ...

  • Industries : Drug and Medication
  • Countries : Austria
Croatia: Antibiotics - Market Report. Analysis and Forecast to 2020

Croatia: Antibiotics - Market Report. Analysis and Forecast to 2020

  • $ 2 161
  • Industry report
  • January 2015
  • by IndexBox Marketing

The report provides an in-depth analysis of the Market for Antibiotics in Croatia. It presents the latest data of the market size and volume, domestic production, exports and imports, price dynamics and ...

  • Industries : Drug and Medication
  • Countries : Croatia
Austria: Heterocyclic Compounds - Market Report. Analysis and Forecast to 2020

Austria: Heterocyclic Compounds - Market Report. Analysis and Forecast to 2020

  • $ 2 161
  • Industry report
  • January 2015
  • by IndexBox Marketing

The report provides an in-depth analysis of the Market for Heterocyclic Compounds in Austria. It presents the latest data of the market size and volume, domestic production, exports and imports, price ...

  • Industries : Drug and Medication
  • Countries : Austria
Austria: Hormones, Prostaglandins, Thromboxanes And Leukotrienes - Market Report. Analysis and Forecast to 2020

Austria: Hormones, Prostaglandins, Thromboxanes And Leukotrienes - Market Report. Analysis and Forecast to 2020

  • $ 2 161
  • Industry report
  • January 2015
  • by IndexBox Marketing

The report provides an in-depth analysis of the Market for Hormones, Prostaglandins, Thromboxanes And Leukotrienes in Austria. It presents the latest data of the market size and volume, domestic production, ...

  • Industries : Drug and Medication
  • Countries : Austria
Bulgaria: Antibiotics - Market Report. Analysis and Forecast to 2020

Bulgaria: Antibiotics - Market Report. Analysis and Forecast to 2020

  • $ 2 161
  • Industry report
  • January 2015
  • by IndexBox Marketing

The report provides an in-depth analysis of the Market for Antibiotics in Bulgaria. It presents the latest data of the market size and volume, domestic production, exports and imports, price dynamics ...

  • Industries : Drug and Medication
  • Countries : Bulgaria
Bulgaria: Heterocyclic Compounds - Market Report. Analysis and Forecast to 2020

Bulgaria: Heterocyclic Compounds - Market Report. Analysis and Forecast to 2020

  • $ 2 161
  • Industry report
  • January 2015
  • by IndexBox Marketing

The report provides an in-depth analysis of the Market for Heterocyclic Compounds in Bulgaria. It presents the latest data of the market size and volume, domestic production, exports and imports, price ...

  • Industries : Drug and Medication
  • Countries : Bulgaria
Bulgaria: Hormones, Prostaglandins, Thromboxanes And Leukotrienes - Market Report. Analysis and Forecast to 2020

Bulgaria: Hormones, Prostaglandins, Thromboxanes And Leukotrienes - Market Report. Analysis and Forecast to 2020

  • $ 2 161
  • Industry report
  • January 2015
  • by IndexBox Marketing

The report provides an in-depth analysis of the Market for Hormones, Prostaglandins, Thromboxanes And Leukotrienes in Bulgaria. It presents the latest data of the market size and volume, domestic production, ...

  • Industries : Drug and Medication
  • Countries : Bulgaria

63 Companies

Read our Company Profiles

GlaxoSmithKline P.L.C.

United States

Johnson and Johnson

United States

Abbott Laboratories

United States

Pfizer Inc.

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.